IRIS
PRETE, MARCELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.540
EU - Europa 1.648
AS - Asia 697
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
AF - Africa 3
OC - Oceania 3
Totale 6.901
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.535
IT - Italia 638
CN - Cina 423
SE - Svezia 400
SG - Singapore 196
UA - Ucraina 151
DE - Germania 130
FI - Finlandia 89
GB - Regno Unito 82
FR - Francia 78
IN - India 29
BE - Belgio 19
VN - Vietnam 16
CZ - Repubblica Ceca 14
IE - Irlanda 14
JP - Giappone 12
CH - Svizzera 6
EU - Europa 5
CA - Canada 4
ID - Indonesia 4
NL - Olanda 4
AT - Austria 3
BR - Brasile 3
ES - Italia 3
HK - Hong Kong 3
IR - Iran 3
KR - Corea 3
AU - Australia 2
BG - Bulgaria 2
HR - Croazia 2
LT - Lituania 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
SA - Arabia Saudita 2
TR - Turchia 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BZ - Belize 1
CL - Cile 1
GR - Grecia 1
HU - Ungheria 1
IM - Isola di Man 1
KH - Cambogia 1
ME - Montenegro 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
SY - Repubblica araba siriana 1
Totale 6.901
Salva come PNG Salva come JPEG
Città #
Chandler 609
Fairfield 444
Woodbridge 376
Jacksonville 366
Nyköping 337
Ashburn 316
Houston 303
Ann Arbor 215
Seattle 215
Cambridge 204
Wilmington 193
Bari 169
Singapore 151
Lawrence 104
Roxbury 104
Beijing 98
Nanjing 98
New York 92
Des Moines 71
Boardman 56
Princeton 49
Inglewood 44
Marseille 32
Milan 31
Brooklyn 28
Shenyang 27
Los Angeles 23
Nanchang 23
Pune 23
Hebei 22
Rome 21
Paris 20
San Diego 20
Santa Clara 20
Brussels 19
Dearborn 19
Dong Ket 16
Palermo 16
Tianjin 15
Guangzhou 14
Noicattaro 14
Jiaxing 12
London 12
Munich 12
Washington 12
Brno 11
Redwood City 11
Changsha 9
Auburn Hills 8
Dublin 7
Florence 7
Grafing 7
Helsinki 7
Wuhan 7
San Mateo 6
Hefei 5
Kunming 5
Norwalk 5
Padova 5
Parma 5
Pontecorvo 5
Siena 5
Ancona 4
Edinburgh 4
Falls Church 4
Indiana 4
Jinan 4
Messina 4
Ningbo 4
Osaka 4
Rho 4
San Francisco 4
Stimigliano 4
Ardabil 3
Arzano 3
Assèmini 3
Cascina 3
Claro 3
Fuzhou 3
Genoa 3
Haikou 3
Incheon 3
Lacchiarella 3
Leawood 3
Lodi 3
Mumbai 3
Naples 3
Porto Recanati 3
Prescot 3
Reggio Emilia 3
Santa Maria Capua Vetere 3
Shanghai 3
Tappahannock 3
Triggiano 3
Verona 3
Vicenza 3
Waterford 3
Wuxi 3
Yiwu 3
Zhengzhou 3
Totale 5.305
Salva come PNG Salva come JPEG
Nome #
L'immunoparesi nel mieloma multiplo 417
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 139
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association 123
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading 123
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis 121
Autoimmune uveitis: clinical, pathogenetic, and therapeutic features 119
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 116
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 114
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 107
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 105
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. 105
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype 104
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases 103
Autoantibodies to intracellular antigens: generation and pathogenetic role 102
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension 96
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease 94
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 92
Vasculitides: Proposal for an integrated nomenclature 91
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center 90
Effectiveness and safety of belimumab in patients with active systemic lupus erythematosus: results from a large, nationwide, multicentric study. 89
CD20: A target antigen for immunotherapy of autoimmune diseases 86
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 86
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 86
Rheumatic disorders as paraneoplastic syndromes 85
Extra-articular manifestations of rheumatoid arthritis: an update 85
Human CD4 internal antigen anti-idiotypic monoclonal antibody. Immunochemical and sequence analysis 83
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 80
Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma 77
null 77
null 76
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma 75
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease 73
B2 microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin’s and non Hodgkin’s lymphomas 71
Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins a case report 71
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 70
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 67
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature 65
Beta2-m-free heavy chain levels of HLA-class I antigen combined with serum IgM or platelet count provide two reliable staging systems in multiple myeloma 62
Analisi molecolare di un anticorpo monoclonale (ACMO) anti-idiotipo 'immagine interna' dell'antigene CD4 62
Case series on amyloidosis and organ involvement: a single center experience 61
Beta2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 60
Identificazione del peptide che mima l'epitopo localizzato sulla catena pesante HLA-I non associata alla beta 2-microglobulina, riconosciuto dall'anticorpo monoclonale HC-10 58
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 58
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 58
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 56
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment 56
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 55
The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myeloma 53
Involvement of FAB subclass-specific determinants in the interaction of human IgG with Streptococcal Protein (PG) 53
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 52
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 51
Minimum structural requirement for CD4 mimicry by anti-idiotipic mAb 16D7 51
Anticorpi monoclonali nell'immunoterapia delle malattie autoimmuni 50
La neutropenia nei pazienti in trattamento: differenziazione dei fattori di crescita 48
Beta-2 microglobulin-free HLA-A class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally toserum FHC expression 48
Monoclonal antibodies (mAb) in the immunotherapy (IT) of autoimmune disease (AD) 47
Clinical use of erythropoietin 47
Anti Th/To autoantibodies: a predictor markers for interstitial lung disease in undifferentiated connective tissue disease at risk of systemic sclerosis 47
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 44
Vasculiti primarie sistemiche 44
Dosaggio della catena pesante degli antigeni di Istocompatibilita' in pazienti con mieloma multiplo (MM) 43
Analisi molecolare di un anticorpo monoclonale (AcMo) anti-idiotipo “immagine interna” dell’antigene CD4 43
null 42
Constrictive pericarditis due to AL amyloidosis: a case report. 42
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 41
BETA-2 microglobulin (beta2m)-free HLA Class I heavy chain as prognostic marker of multiple myeloma 40
Amicrobial pustulosis or erosive pustular dermatosis of the inguinal folds: broad of the same spectrum? 40
Immunoparesisi in multiple myeloma 39
null 39
null 39
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 39
Beta 2-microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin's and non-Hodgkin's lymphomas 38
null 38
Membrane-type metalloprotease activity and HLA class I mRNA splicing in generating tFHC variants in multiple myeloma: clinical significance 38
null 37
Ruolo degli autoanticorpi nelle patologie autoimmuni 36
null 36
Vasculiti primarie sistemiche 36
null 34
null 33
null 33
null 33
Echocardiographic alteration in patients with systemic lupus erythematosus affected by hepatic steatosis: a cross-sectional single center study 33
Monoclonal antibodies in the immunotherapy of autoimmune diseases 32
Serum levels of beta2-microglobulin-free heavy chain of HLA class I antigen are increased in patients with multiple myeloma. Role of FHC size variant 31
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 31
Raynaud’s phenomenon: from molecular pathogenesis to therapy 31
An atypical presentation of intestinal neuroendocrine tumor. 31
Biomolecular drugs in IBD: news, limits and perspective 30
Two structurally different peptides mimic a CD20 epitope recognized by rituximab 30
Functional characterization of peptides mimicking the CD20 epitope recognized by Rituximab 30
Serum levels of beta2-microglobulin-free heavy chain class I antigen are increased in patients with multiple myeloma. Role of FHC size variants 29
Efficacy, Safety, and Predictor of Response to Belimumab in a Large Nationwide Cohort Study of Patients with Active Systemic Lupus Erythematosus. 29
Lupus vasculitis: An overview 29
Generation of linear and cyclic peptides revealed a unique fine specificity of Rituximab and its possible cross-reactivity with an acid sphingomyelinase-like phosphodiesterasem 3B precursor 28
Galectin-3 and Neutrophil-to-Lymphocyte ratio are indicative of heart remodelling and disease severity in patients with Obstructive Sleep Apnoea 27
Un esempio di mimotipo per l'iimunoterapia delle patologie autoimmuni 27
null 27
Dosaggio della catena pesante degli antigeni di istocompatibilità di classe I (HLA-I) nel siero di pazienti con mieloma multiplo 26
null 26
Totale 6.350
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.222
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020926 0 0 0 0 150 115 144 93 151 81 157 35
2020/20211.294 114 30 104 61 191 71 186 109 133 138 97 60
2021/2022816 35 88 6 34 28 66 60 46 39 43 143 228
2022/20231.560 195 207 116 143 171 218 34 180 220 11 46 19
2023/2024717 50 111 38 65 52 182 14 50 23 30 25 77
2024/2025440 91 27 193 73 56 0 0 0 0 0 0 0
Totale 7.279